Dave Lemus
Before joining the medical commercialisation specialist, Lemus was CFO for MorphoSys, where he launched Germany’s first biotech IPO in 1999.
Trevor Jones, president of the company, said: "We are delighted to appoint Dave to lead our efforts to expand the world-class rare disease business we have established in the US. Dave brings a wealth of relevant pharmaceutical and biotech experience from both the US. and Europe.”